Presynaptic dysfunction in Huntington's disease

Biochemical Society Transactions

Volumn 38, Issue 2, 2010, Pages 488-492

  Rozas, José L ^a,b   Gómez Sánchez, Leonardo ^a,b   Tomás Zapico, Cristina ^b,c   Lucas, José J ^b,c   Fernández Chacón, Rafael ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

Cysteine string protein (CSP); Huntingtin (htt); Neuromuscular junction (NMJ); Neurotransmitter release; R6 1

Indexed keywords

PROTEASOME; UBIQUITIN; NERVE PROTEIN;

DROSOPHILA; EXOCYTOSIS; HUNTINGTON CHOREA; NERVE DEGENERATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; ANIMAL; DISEASE MODEL; HUMAN; METABOLISM; MOUSE; NERVE CELL NETWORK; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTOSOME;

ANIMALIA;

ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA; HUMANS; HUNTINGTON DISEASE; MICE; NERVE NET; NERVE TISSUE PROTEINS; PRESYNAPTIC TERMINALS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 77953275957     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0380488     Document Type: Review

References (50)

1. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983
2. Ferrante, R.J. (2009) Mouse models of Huntington's disease and methodological considerations for therapeutic trials. Biochim. Biophys. Acta 1792, 506-520
3. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. and Bates, G.P. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506
4. Diaz-Hernandez, M., Moreno-Herrero, F., Gomez-Ramos, P., Moran, M.A., Ferrer, I., Baro, A.M., Avila, J., Hernandez, F. and Lucas, J.J. (2004) Biochemical, ultrastructural, and reversibility studies on huntingtin filaments isolated from mouse and human brain. J. Neurosci. 24, 9361-9371
5. Diaz-Hernandez, M., Torres-Peraza, J., Salvatori-Abarca, A., Moran, M.A., Gomez-Ramos, P., Alberch, J. and Lucas, J.J. (2005) Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease. J. Neurosci. 25, 9773-9781
6. Faber, P.W., Alter, J.R., MacDonald, M.E. and Hart, A.C. (1999) Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc. Natl. Acad. Sci. U.S.A. 96, 179-184
7. Jackson, G.R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P.W., MacDonald, M.E. and Zipursky, S.L. (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21, 633-642
8. Lee, W.C., Yoshihara, M. and Littleton, J.T. (2004) Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 101, 3224-3229
9. Dunah, A.W., Jeong, H., Griffin, A., Kim, Y.M., Standaert, D.G., Hersch, S.M., Mouradian, M.M., Young, A.B., Tanese, N. and Krainc, D. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296, 2238-2243
10. Ortega, Z., Diaz-Hernandez, M. and Lucas, J.J. (2007) Is the ubiquitin-proteasome system impaired in Huntington's disease? Cell. Mol. Life Sci. 64, 2245-2257
11. Trushina, E., Singh, R.D., Dyer, R.B., Cao, S., Shah, V.H., Parton, R.G., Pagano, R.E. and McMurray, C.T. (2006) Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum. Mol. Genet. 15, 3578-3591
12. Gunawardena, S., Her, L.S., Brusch, R.G., Laymon, R.A., Niesman, I.R., Gordesky-Gold, B., Sintasath, L., Bonini, N.M. and Goldstein, L.S. (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40, 25-40
13. Morfini, G.A., You, Y.M., Pollema, S.L., Kaminska, A., Liu, K., Yoshioka, K., Bjorkblom, B., Coffey, E.T., Bagnato, C., Han, D. et al. (2009) Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat. Neurosci. 12, 864-871
14. Gauthier, L.R., Charrin, B.C., Borrell-Pages, M., Dompierre, J.P., Rangone, H., Cordelieres, F.P., De Mey, J., MacDonald, M.E., Lessmann, V., Humbert, S. and Saudou, F. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127-138
15. Tang, T.S., Guo, C., Wang, H., Chen, X. and Bezprozvanny, I. (2009) Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model. J. Neurosci. 29, 1257-1266
16. Tang, T.S., Tu, H., Chan, E.Y., Maximov, A., Wang, Z., Wellington, C.L., Hayden, M.R. and Bezprozvanny, I. (2003) Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 39, 227-239
17. Tang, T.S., Tu, H., Orban, P.C., Chan, E.Y., Hayden, M.R. and Bezprozvanny, I. (2004) HAP1 facilitates effects of mutant huntingtin on inositol 1,4,5-trisphosphate-induced Ca release in primary culture of striatal medium spiny neurons. Eur. J. Neurosci. 20, 1779-1787
18. Smith, R., Brundin, P. and Li, J.Y. (2005) Synaptic dysfunction in Huntington's disease: a new perspective. Cell. Mol. Life Sci. 62, 1901-1912
19. Zeron, M.M., Hansson, O., Chen, N., Wellington, C.L., Leavitt, B.R., Brundin, P., Hayden, M.R. and Raymond, L.A. (2002) Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33, 849-860
20. Romero, E., Cha, G.H., Verstreken, P., Ly, C.V., Hughes, R.E., Bellen, H.J. and Botas, J. (2008) Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm. Neuron 57, 27-40
21. Swayne, L.A., Chen, L., Hameed, S., Barr, W., Charlesworth, E., Colicos, M.A., Zamponi, G.W. and Braun, J.E. (2005) Crosstalk between huntingtin and syntaxin 1A regulates N-type calcium channels. Mol. Cell Neurosci. 30, 339-351
22. 2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 102, 2602-2607
23. Diaz-Hernandez, M., Diez-Zaera, M., Sanchez-Nogueiro, J., Gomez-Villafuertes, R., Canals, J.M., Alberch, J., Miras-Portugal, M.T. and Lucas, J.J. (2009) Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration. FASEB J. 23, 1893-1906
24. Miller, L.C., Swayne, L.A., Chen, L., Feng, Z.P., Wacker, J.L., Muchowski, P.J., Zamponi, G.W. and Braun, J.E. (2003) Cysteine string protein (CSP) inhibition of N-type calcium channels is blocked by mutant huntingtin. J. Biol. Chem. 278, 53072-53081
25. Fernández-Chacón, R., Wolfel, M., Nishimune, H., Tabares, L., Schmitz, F., Castellano-Munoz, M., Rosenmund, C., Montesinos, M.L., Sanes, J.R., Schneggenburger, R. and Südhof, T.C. (2004) The synaptic vesicle protein CSPα prevents presynaptic degeneration. Neuron 42, 237-251
26. Cummings, D.M., Andre, V.M., Uzgil, B.O., Gee, S.M., Fisher, Y.E., Cepeda, C. and Levine, M.S. (2009) Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J. Neurosci. 29, 10371-10386
27. Cepeda, C., Hurst, R.S., Calvert, C.R., Hernandez-Echeagaray, E., Nguyen, O.K., Jocoy, E., Christian, L.J., Ariano, M.A. and Levine, M.S. (2003) Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J. Neurosci. 23, 961-969
28. Cepeda, C., Starling, A.J., Wu, N., Nguyen, O.K., Uzgil, B., Soda, T., Andre, V.M., Ariano, M.A. and Levine, M.S. (2004) Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. J. Neurosci. Res. 78, 855-867
29. Smith, R., Petersen, A., Bates, G.P., Brundin, P. and Li, J.Y. (2005) Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction. Neurobiol. Dis. 20, 673-684
30. Smith, R., Klein, P., Koc-Schmitz, Y., Waldvogel, H.J., Faull, R.L., Brundin, P., Plomann, M. and Li, J.Y. (2007) Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease. J. Neurochem. 103, 115-123
31. Deak, F., Shin, O.H., Tang, J., Hanson, P., Ubach, J., Jahn, R., Rizo, J., Kavalali, E.T. and Südhof, T.C. (2006) Rabphilin regulates SNARE-dependent re-priming of synaptic vesicles for fusion. EMBO J. 25, 2856-2866
32. Fernández-Chacón, R. and Südhof, T.C. (2000) Novel SCAMPs lacking NPF repeats: ubiquitous and synaptic vesicle-specific forms implicate SCAMPs in multiple membrane-trafficking functions. J. Neurosci. 20, 7941-7950
33. Noh, J.Y., Lee, H., Song, S., Kim, N.S., Im, W., Kim, M., Seo, H., Chung, C.W., Chang, J.W., Ferrante, R.J. et al. (2009) SCAMP5 links endoplasmic reticulum stress to the accumulation of expanded polyglutamine protein aggregates via endocytosis inhibition. J. Biol. Chem. 284, 11318-11325
34. Metzler, M., Li, B., Gan, L., Georgiou, J., Gutekunst, C.A., Wang, Y., Torre, E., Devon, R.S., Oh, R., Legendre-Guillemin, V. et al. (2003) Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking. EMBO J. 22, 3254-3266
35. Parker, J.A., Metzler, M., Georgiou, J., Mage, M., Roder, J.C., Rose, A.M., Hayden, M.R. and Neri, C. (2007) Huntingtin-interacting protein 1 influences worm and mouse presynaptic function and protects Caenorhabditis elegans neurons against mutant polyglutamine toxicity. J. Neurosci. 27, 11056-11064
36. Dittman, J.S. and Kaplan, J.M. (2006) Factors regulating the abundance and localization of synaptobrevin in the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 103, 11399-11404
37. Parker, J.A., Holbert, S., Lambert, E., Abderrahmane, S. and Neri, C. (2004) Genetic and pharmacological suppression of polyglutamine-dependent neuronal dysfunction in Caenorhabditis elegans. J. Mol. Neurosci. 23, 61-68
38. Huang, K., Yanai, A., Kang, R., Arstikaitis, P., Singaraja, R.R., Metzler, M., Mullard, A., Haigh, B., Gauthier-Campbell, C., Gutekunst, C.A. et al. (2004) Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron 44, 977-986
39. Ohyama, T., Verstreken, P., Ly, C.V., Rosenmund, T., Rajan, A., Tien, A.C., Haueter, C., Schulze, K.L. and Bellen, H.J. (2007) Huntingtin-interacting protein 14, a palmitoyl transferase required for exocytosis and targeting of CSP to synaptic vesicles. J. Cell Biol. 179, 1481-1496
40. Stowers, R.S. and Isacoff, E.Y. (2007) Drosophila huntingtin-interacting protein 14 is a presynaptic protein required for photoreceptor synaptic transmission and expression of the palmitoylated proteins synaptosome-associated protein 25 and cysteine string protein. J. Neurosci. 27, 12874-12883
41. Chandra, S., Gallardo, G., Fernández-Chacón, R., Schluter, O.M. and Südhof, T.C. (2005) α-Synuclein cooperates with CSPα in preventing neurodegeneration. Cell 123, 383-396
42. Hershko, A. and Ciechanover, A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479
43. Cummings, C.J., Mancini, M.A., Antalffy, B., DeFranco, D.B., Orr, H.T. and Zoghbi, H.Y. (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 19, 148-154
44. Bence, N.F., Sampat, R.M. and Kopito, R.R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555
45. Diaz-Hernandez, M., Valera, A.G., Moran, M.A., Gomez-Ramos, P., Alvarez-Castelao, B., Castano, J.G., Hernandez, F. and Lucas, J.J. (2006) Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain. J. Neurochem. 98, 1585-1596
46. Bennett, E.J., Shaler, T.A., Woodman, B., Ryu, K.Y., Zaitseva, T.S., Becker, C.H., Bates, G.P., Schulman, H. and Kopito, R.R. (2007) Global changes to the ubiquitin system in Huntington's disease. Nature 448, 704-708
47. Bett, J.S., Cook, C., Petrucelli, L. and Bates, G.P. (2009) The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington's disease. PLoS ONE 4, e5128
48. Maynard, C.J., Bottcher, C., Ortega, Z., Smith, R., Florea, B.I., Diaz-Hernandez, M., Brundin, P., Overkleeft, H.S., Li, J.Y., Lucas, J.J. and Dantuma, N.P. (2009) Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment. Proc. Natl. Acad. Sci. U.S.A. 106, 13986-13991
49. Wang, J., Wang, C.E., Orr, A., Tydlacka, S., Li, S.H. and Li, X.J. (2008) Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. J. Cell Biol. 180, 1177-1189
50. Willeumier, K., Pulst, S.M. and Schweizer, F.E. (2006) Proteasome inhibition triggers activity-dependent increase in the size of the recycling vesicle pool in cultured hippocampal neurons. J. Neurosci. 26, 11333-11341